40 years of experience in biotech management and venture capital investments. Mr. Linsert is the founder, President and CEO of Columbia Biosciences Corporation (CBC). Prior to founding CBC, Mr. Linsert was Chairman and CEO of Martek Biosciences Corporation from 1989 to 2006. As CEO he took a small private R&D company to a highly profitable public company with a market capitalization of over $1-billion.

Henry 'Pete" Linsert - Executive Chairman

See Management Page

Hao Chen, PHD

Board of Directors

More than 30 years of biotech/pharmaceutical and energy sector experience. Dr. Pavia currently serves as Chief Technology Officer of Glori Energy, a company focused on using microbiology to increase oil production from existing wells. He is also a member of the board of directors of Azevan Pharmaceuticals. Dr. Pavia was Entrepreneur-in-Residence with the venture capital firm Oxford Bioscience Partners, a firm most recently focused on applying novel biology and chemistry to biotech and energy solutions. Prior to joining Oxford, Dr. Pavia was Chief Technology Officer at Millennium Pharmaceuticals.

Mike Pavia - Member of the Board

© 2017 DRI Bioscicences Corporation, All Rights Reserved.

  • Facebook Clean
  • LinkedIn Clean
  • Google+ Clean